Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bristol-Myers Squibb brings Chinese activities under one roof:

This article was originally published in Clinica

Executive Summary

Bristol-Myers Squibb will set up a new business unit incorporating all its divisions active in China. The unit will be headed by Jack Wolinetz in the newly-created position of president, China, Bristol-Myers Squibb. He will report to Samuel Hamad, president, intercontinental, who says that BMS has seen significant growth in China as a result of strong relationships with its joint-venture partners and a solid investment strategy. In July, BMS' ConvaTec medical device subsidiary opened its first manufacturing plant in what was BMS' third Chinese joint venture (see Clinica No 661, p 12).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT093358

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel